Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Capdevielle

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Brain, Behavior, & Immunity - Health|October 6, 2025
Inflammation, childhood trauma, and symptom dimensions in schizophrenia: a path-analysis studyFrancisca Silva, Andrei Szöke, Mohamed Lajnef, et al.
Psychiatry Research|June 3, 2025
Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohortKaori Saitoh, Mohamed Lajnef, Wahid Boukouaci, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2025
Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not associationSusana Barbosa, Ryad Tamouza, Marion Leboyer, et al.
Cell Death & Disease|July 8, 2020
Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)Adrien Joseph, Stéphanie Moriceau, Valentina Sica, et al.
Brain, Behavior, and Immunity|February 1, 2026
From non-specific biomarker to targeted action: transdiagnostic and sex-specific drivers of high-CRP status in severe mental illness across the FondaMental Advanced Centers of Expertise (FACE) cohortsTim Rietberg, Susana Barbosa, Pieter Meysman, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Brain, Behavior, & Immunity - Health|October 6, 2025
Inflammation, childhood trauma, and symptom dimensions in schizophrenia: a path-analysis studyFrancisca Silva, Andrei Szöke, Mohamed Lajnef, et al.
Psychiatry Research|June 3, 2025
Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohortKaori Saitoh, Mohamed Lajnef, Wahid Boukouaci, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2025
Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not associationSusana Barbosa, Ryad Tamouza, Marion Leboyer, et al.
Cell Death & Disease|July 8, 2020
Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)Adrien Joseph, Stéphanie Moriceau, Valentina Sica, et al.
Brain, Behavior, and Immunity|February 1, 2026
From non-specific biomarker to targeted action: transdiagnostic and sex-specific drivers of high-CRP status in severe mental illness across the FondaMental Advanced Centers of Expertise (FACE) cohortsTim Rietberg, Susana Barbosa, Pieter Meysman, et al.
Pageof 13